Health Care/Hospital
Ceva Santé Animale launches the 2024 edition of its "Call for Projects" to help advance the human-animal bond
LIBOURNE, France, Sept. 19, 2023 /PRNewswire/ -- After the success of its first European edition last year, Ceva Santé Animale (Ceva), the #5 global animal health company, present in 110 countries worldwide, is pleased to announce the launch of its highly anticipated2024 "Call for Projects". This...
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment
TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway), a biopharmaceutical company focusing on breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics, announced the completion of subject recruitment in the CBL-0201EFP Phase 2-stage...
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand...
Agilent and NCCS Sign Research Collaboration Agreement to Advance Singapore's Genomic Profiling on Asian-prevalent Cancers
SINGAPORE, Sept. 19, 2023 /PRNewswire/ -- Agilent Technologies Inc.
Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen
Interim results of operational research in LIFT-TB countries support decision to roll out improved treatment PRETORIA, South Africa, Sept. 19, 2023 /PRNewswire/ -- Kyrgyzstan, Ukraine, andUzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinical Gu...
Latest Blood Cancer Treatment Updates Presented at Annual NCCN Event During Blood Cancer Awareness Month
NCCN 2023 Annual Congress: Hematologic Malignancies features expert perspectives on developments in blood cancer treatment, including NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Updates, CAR T-Cell therapy, BTK Inhibitors, Bispecific T-Cell Engagers, and More SAN FRANCISCO, S...
VUNO's First AI-based Prospective Study Results Published in Critical Care
SEOUL, South Korea, Sept. 18, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company announced that its AI-based cardiac arrest risk management system, VUNO Med®-DeepCARS™, has proven its clinical validity for the first time through a prospective study utilizing Real World Data(RWD). <...
Lexasure Financial Group Founder & CEO Ian Lim to Receive BrandLaureate Awards for Digital Insurance Solutions and Visionary Entrepreneur of the Year
GEORGETOWN, Cayman Islands, Sept. 18, 2023 /PRNewswire/ -- Lexasure Financial
Group Limited
Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor
ALAMEDA, Calif. and TAIPEI, Sept. 18, 2023 /PRNewswire/ -- Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address gaps in cancer care, today announced that N...
Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital
GUANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- On September 13th, Canton Biologics Co., Ltd. announced that it had recently completed a Series C financing round exceeding300 million yuan. This round of financing was led by SDIC Venture Capital, with participation from Guangdong Technology Finan...
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Funding supports development and testing of proprietary FieldBending™ catheter ablation platform CARDIFF-BY-THE-SEA, Calif., Sept. 18, 2023 /PRNewswire/ -- Field Medical, Inc. (Field Medical), an emerging leader in cardiac catheter ablation, announced today that it has closed its oversubscribed ...
Biosyngen received the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2023
SINGAPORE, Sept. 18, 2023 /PRNewswire/ -- On September 14, 2023, Biosyngen Pte Ltd (hereinafter referred to as "Biosyngen") was the recipient of the prestigious "Most Promising Cell Therapy Pipeline in APAC" award at the 7th Annual Cell & Gene Therapy World Asia 2023, amidst a pool of internation...
Broncus Announced Long-Term Follow-Up Data on InterVapor, Showing Stable Long-Term Efficacy in Patients
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- During the 23th ERS International Congress onSeptember 11, Broncus announced long-term follow-up data about Bronchoscopic Thermal Vapor Ablation (BTVA) treatment using InterVapor®, the Company's product for the treatment of Chronic Obstructive Pulm...
Global Times: China's medical assistance boosts healthcare development in South Pacific region
BEIJING, Sept. 18, 2023 /PRNewswire/ -- "For this surgery, we have prepared for more than half a year," Xiao Yuehai told the Global Times when talking about the first laparoscopic surgery carried out inSolomon Islands. Xiao is an urologist from the Affiliated Hospital of Guizhou Medical Universi...
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
HANGZHOU, China, Sept. 18, 2023 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock was added to the FTSE Global Equity Index Series ("GEIS"), including FTSE Global Total-Cap Index (LMSµ) and FTSE Global Micro Cap Index, according to the results o...
Peak Asia Pacific fertility body endorses reform blueprint to create more family friendly societies
ADELAIDE, Australia, Sept. 18, 2023 /PRNewswire/ -- A unique reform blueprint to advance family friendly policies and arrest falling birth rates will be championed across theAsia Pacific by the peak body representing scientists, doctors, nurses and counsellors in assisted reproduction in the regi...
Eastheath Trading Consolidates Its Inca Oil Nutritional Product Line Under the Brand "ZHEN YOU MEI" for Global Marketing
KAOHSIUNG, Sept. 18, 2023 /PRNewswire/ -- Eastheath Trading Co., Ltd.
Biotropics Malaysia Berhad Unveils Novel Brain Health Ingredient at Vitafoods Asia 2023
BANGKOK, Sept. 18, 2023 /PRNewswire/ -- September 20, 2023, Biotropics Malaysia Berhad, a leading producer of high-quality botanical extracts, is pleased to announce the launch of its novel BioKesum® leaf extract clinically shown to support brain health. BioKesum® leaf extract is sourced from the...
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biolog...
New drug class prevents key ageing mechanism in organ transplants
ATHENS, Greece, Sept. 18, 2023 /PRNewswire/ -- A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of senescence, a key mechanism of ageing, in recipients of older donor organs. The pioneering research, presented today at the European Societ...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00